Researchers found that the APOE4 protein variant alters how brain immune cells handle fat and trigger inflammation, offering new clues into Alzheimer's risk.

Researchers at the University of Colorado Anschutz and Pacific Northwest National Laboratory have published a new study exploring how the APOE4 gene variant, a well-known genetic risk factor for Alzheimer's disease, affects the brain's immune cells. The findings suggest that the protein changes how these cells handle fat and trigger inflammation, providing insight into why the gene elevates Alzheimer's risk.

How ApoE and Fat Function in the Brain

The brain relies on internal fat-carrying particles to move fat between cells and keep them healthy, because circulating fat cannot enter the brain directly. Senior author Kimberley D. Bruce explained that the ApoE protein acts like a belt holding these particles together. The study found that the way ApoE4 carries lipids causes cells to retain fat, breaking the fat cycle and triggering inflammation.

Impact on Microglia and Energy Storage

The researchers studied human microglia, the brain's immune cells that act as a cleanup and security crew. When treated with ApoE4, these cells stored fat differently by developing fewer but larger fat droplets and had fewer mitochondria to turn fat into energy. The effects depended on whether the protein was carrying fat: fat-carrying ApoE4 altered fat and energy storage, while fat-free ApoE4 triggered a stronger inflammatory immune response.

Future Implications and Study Limitations

While the study points to a possible answer regarding how APOE4 increases Alzheimer's risk, the researchers emphasize that it does not show that APOE4 causes Alzheimer's disease and does not provide a new treatment. Future exploration could focus on finding ways to make ApoE4 carry more fat or blocking the inflammation triggered by fat-free ApoE4. The laboratory research on human brain immune cells still requires further work to determine if the same changes happen in humans.